Spyre Therapeutics Inc (SYRE)

Financing Cash Flow

$753.03M

TTM · Period ending: · USD

SYRE logo

SYRE Financing Cash Flow

Latest reported$753.03M
SYRE TTM Cash from Financing ($5.58M → $753.03M)
High-resolution chart · PNG

SYRE financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Spyre Therapeutics Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
753,027,000
321,155,000
309,025,000
221,814,000
239,237,000
238,866,000
410,906,000
348,911,000
323,600,000
533,232,000
361,077,000
197,463,000
209,864,000
42,676,000
42,678,000
42,766,000
44,039,000
1,043,000
1,393,000
25,992,000
25,107,000
154,592,000
154,512,000
130,509,000
130,562,000
950,000
65,723,000
82,308,000
83,053,000
121,435,000
57,068,000
40,491,000
39,317,000
12,805,000
12,213,000
11,529,000
11,723,000
49,564,000
49,370,000
49,167,000
48,121,000
-2,102,000
41,674,000
41,877,000
48,422,000
49,253,000
5,575,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.